Clinical Operations Services
Clinical operations are the key component behind successful clinical research and are responsible for designing, conducting, and managing Phase I– IV trials.
.png)
As clinical trials have become more complex due to increased guidance and regulations, there's more pressure than ever on clinical operations teams. While some organizations may invest more time and effort in this area, others are outsourcing their clinical trials to CROs with deep expertise in the specific field of research that provide robust, end-to-end services to execute their trials successfully.
Our clinical operations team works with sponsors to optimize clinical trial design, support efficient study execution, implement patient-centric approaches, and guide studies through the clinical development lifecycle. ProPharma is specialized in connecting clinical operations expertise with related services across regulatory strategy, study start-up, clinical monitoring, eTMF, CTMS, and medical device clinical development.
Phase I Services
We provide teams with clinical expertise and an extended suite of early-phase clinical development services specifically engineered to accelerate study progression. Together, our clinical operations team will successfully lead and execute your proof-of-concept study to Phase 2 trial.
Our Key Clinical Operations-Related Service Offerings Include:
- Site selection and feasibility
- Clinical monitoring services
- Electronic Trial Master File (eTMF) and clinical trial management system (CTMS) support
- Site training and study conduct
- Clinical program and project management
Work With Our Experienced Clinical Operations Experts
Our clinical operations leaders have the expertise to help you design, conduct, and manage clinical trials for drugs and medical devices. Whether you need a partner to assist internal teams with the workload or outsource your entire clinical trial, our experts are here to provide support.
News & Insights
July 20, 2026
Building Relationships with Sites: The Hidden Driver of Faster Start-Ups
Discover effective strategies for building relationships with clinical trial sites to streamline the study start-up process and enhance activation timelines.
July 17, 2026
FDA Weighs in on Popular Peptides
FDA is reviewing seven popular peptides for potential inclusion on the 503A Bulks List. Learn what the review means for compounding pharmacies and patient access.
July 14, 2026
First Joint Clinical Assessments (JCAs): Key Lessons for EU HTA
Learn what the first EU Joint Clinical Assessments reveal about evidence planning, PICO strategy, and HTA readiness for successful market access.
.png?width=320&height=185&name=6%20-%20Medical%20Information%20%20(650%20x%20425%20px).png)
.png?width=320&height=185&name=4%20-%20Quality%20%26%20Compliance%20(650%20x%20425%20px).png)
.png?width=320&height=185&name=Webinar%20Thumbnail%20Quality%20%26%20Compliance%20(650%20x%20425%20px).png)
News & Insights
July 8, 2026
ProPharma Advances Technology Enablement Strategy with AI-Assisted Capability fo...
ProPharma unveils an AI-assisted capability to enhance ANDA submission development, improving efficiency and maintaining regulatory excellence for clients.
June 18, 2026
ProPharma Welcomes Kevin van Dooren to Strengthen Integrated EU Regulatory and H...
ProPharma welcomes Kevin van Dooren as Vice President, HEOR and Market Access, strengthening integrated EU regulatory, HTA, reimbursement, and market access capabilities for life sciences companies.
May 27, 2026
ProPharma Appoints Adrian Pencak as Chief Commercial Officer
ProPharma announces Adrian Pencak as Chief Commercial Officer, bringing 25 years of leadership experience to enhance global commercial capabilities and client partnerships.
